ENTA vs TXN · rev $65.3M vs P/E 52, rev $10.29B
Enanta Pharmaceuticals Inc (ENTA) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. ENTA currently screens at market cap $328.0M.
Latest reported TXN revenue for 2026-06-30 was $10.29B. Net income was $3.52B. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
ENTA currently screens at market cap $328.0M. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the ENTA and TXN stock pages for the full models.
Not investment advice.